Anneleen Daemen
Executive Director of Translational Medicine @ORIC Pharmaceuticals Inc.
Signup · Get unlimited contacts
WORK HISTORY
Executive Director of Translational Medicine @ORIC Pharmaceuticals Inc.
South San Francisco, CA, US
Head of Translational Medicine and Bioinformatics• Represents Translational Medicine on late-stage research teams, by implementing and executing strategies for choice of indication, patient selection and identification of markers of early biological activity, and by contributing to drafting study reports, IND filing, investigator brochure, patents, assay protocols, and peer-reviewed scientific publications• Represents Translational Medicine on clinical stage teams, with contributions including devising and implementing a biomarker strategy, the identification, development and validation of assays, writing biomarker sections of clinical protocols and informed consent forms, engagement of CROs, implementation of assays, and interpretation of data. Develops translational datasets to drive recommendations on dose level and schedule for early phase clinical trials, in close collaboration with the clinical, legal, regulatory, biostatistics and clinical operations teams. Drives the development of a CDx assay in collaboration with the clinical, biostatistics, regulatory groups and CROs.• Pharmacology, translational and biomarker lead for PRC2 inhibitor ORIC-944• Companion Diagnostics, biomarker and bioinformatics lead for EGFR/HER2 inhibitor ORIC-114• Member of the Research Leadership Team, reporting to the CSO
EDUCATION
College Heilig Kruis St.Ursula 2
Mathematics - Science
Lemmensinstituut Leuven
Bachelor, Bachelor of Music in Piano
KU Leuven
Ir., Electrical Engineer, specialized in Biomedical Techniques
SKILLS
ABOUT ANNELEEN DAEMEN
I am an experienced scientist and group leader with a keen interest in precision medicine, translational research, and biomarker discovery for hormonal-driven and lung cancer. My major focus is on exploiting cancer heterogeneity to enhance our understanding of biology, translate into a biomarker strategy, and inform clinical development. I have >15 years of experience in next generation sequencing analysis for translational oncology, bioinformatics for drug development, and biomarker discovery. I’m an inclusive leader with a distinguished publication record of >80 peer-reviewed articles and have an extensive background in molecular biology, genetics and genomics. I thrive in a fast-paced, dynamic, cross-functional environment, and care about leadership and people management.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.